Clinical outcomes of COVID-19 in hemodialysis patients in the city of Zonguldak, Turkey

Basit Öğe Kaydı
dc.authoridISLAM, MAHMUD/0000-0003-1284-916X
dc.authoridOZTURK, YASIN/0000-0003-2634-2677
dc.contributor.authorIslam, Mahmud
dc.contributor.authorOzturk, Yasin
dc.contributor.authorKoc, Yener
dc.date.accessioned2024-10-26T18:09:31Z
dc.date.available2024-10-26T18:09:31Z
dc.date.issued2021
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractPurpose Patients on maintenance hemodialysis are vulnerable to viral infections like COVID-19 because of the low chance of obedience and complying with rules besides the need for transfer to distant dialysis facilities. We investigated the impact and clinical effect of treatment of COVID-19 in dialysis patients. Methods We included patients on maintenance hemodialysis at different healthcare facilities in Zonguldak city. With the diagnosis of the first infected HD case, all other patients who shared the same session were screened. Hospitalized and clinically confirmed cases were included. COVID-19 diagnosis was made based on clinical, biochemical along radiologic findings. Results 34 (F/M:19/15, mean age 62 +/- 13.2 years, dialysis duration 66.9 +/- 57.7 months, length of hospital stay 16.2 +/- 7.9 days) were diagnosed with COVID-19 infection. The prevalence of COVID-19 was found to be 18.4% of our exposed population. 38.2% of our patients were initially diagnosed by CT screening while asymptomatic. 35.3% had a fever as the first presenting symptom. Lymphopenia was the most common laboratory finding. Except for one, all had at least one comorbidity. Out of 12 (35.3%) patients admitted to ICU 6(17.6%) died. The deceased patients were older, presented with lower serum albumin and lymphocyte count, and had higher CRP and fibrinogen levels. High CRP level on admission was the only significant predictor of mortality. Conclusion Early detection will lower mortality. In this study, with a low prevalence of COVID-19, the importance of early screening of both symptomatic and asymptomatic patients was shown to be highly important. Further studies are still needed to find out the most appropriate medical management.
dc.identifier.doi10.1007/s11255-020-02781-8
dc.identifier.endpage1452
dc.identifier.issn0301-1623
dc.identifier.issn1573-2584
dc.identifier.issue7
dc.identifier.pmid33449272
dc.identifier.scopus2-s2.0-85100385471
dc.identifier.scopusqualityQ2
dc.identifier.startpage1445
dc.identifier.urihttps://doi.org/10.1007/s11255-020-02781-8
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30156
dc.identifier.volume53
dc.identifier.wosWOS:000607962600001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofInternational Urology and Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID-19
dc.subjectHemodialysis
dc.subjectSARS-CoV-2
dc.subjectChronic renal failure
dc.subjectFiliation
dc.titleClinical outcomes of COVID-19 in hemodialysis patients in the city of Zonguldak, Turkey
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksyonu
Scopus İndeksli Yayınlar Koleksiyonu